Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

IRulya Therapeutics Inc. IRLA

Full chart Compare
Set alert

Price alert · IRLA

All alert types
28.50 USD -3.17 (-10.01%)

Nov 5, 2026, 12:15 PM EST

28.36 Day range 30.47
15.10 52-week range 910.00
YTD
-95.75%
1 year
-90.98%

Financial health

Altman Z-Score

-5.22 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -2.0×
FY 2017: -57.7×FY 2018: -56.7×FY 2019: -29.1×FY 2020: -10.6×FY 2021: -4.2×FY 2022: -0.4×FY 2023: -1.3×FY 2024: -1.4×FY 2025: -2.0×
FY 2017 5y median -1.4× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B -4.7×
FY 2017: -35.0×FY 2018: 9.9×FY 2019: 9.3×FY 2020: 4.7×FY 2021: 3.2×FY 2022: 0.2×FY 2023: 0.5×FY 2024: 2.7×FY 2025: -4.7×
FY 2017 5y median 0.5× FY 2025
P/FCF -4.0×
FY 2017: -71.6×FY 2018: -59.5×FY 2019: -32.1×FY 2020: -15.9×FY 2021: -5.9×FY 2022: -0.5×FY 2023: -2.1×FY 2024: -2.5×FY 2025: -4.0×
FY 2017 5y median -2.5× FY 2025
EV/EBITDA -2.2×
FY 2017: -68.6×FY 2018: -56.7×FY 2019: -26.1×FY 2020: -9.5×FY 2021: -3.4×FY 2022: 0.4×FY 2023: -1.2×FY 2024: -2.5×FY 2025: -2.2×
FY 2017 5y median -2.2× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -24.9%
FY 2017: -1.4%FY 2018: -1.7%FY 2019: -3.1%FY 2020: -6.3%FY 2021: -16.8%FY 2022: -207.0%FY 2023: -47.2%FY 2024: -39.8%FY 2025: -24.9%
FY 2017 5y median -39.8% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE 235.1%
FY 2017: 60.3%FY 2018: -17.5%FY 2019: -32.0%FY 2020: -44.6%FY 2021: -75.8%FY 2022: -51.4%FY 2023: -36.9%FY 2024: -188.5%FY 2025: 235.1%
FY 2017 5y median -51.4% FY 2025
ROIC -73.7%
FY 2017: -174.1%FY 2018: -17.0%FY 2019: -33.9%FY 2020: -45.7%FY 2021: -75.4%FY 2022: -51.1%FY 2023: -20.2%FY 2024: -53.4%FY 2025: -73.7%
FY 2017 5y median -53.4% FY 2025
ROA -89.8%
FY 2017: -158.5%FY 2018: -17.1%FY 2019: -29.7%FY 2020: -40.6%FY 2021: -67.5%FY 2022: -49.7%FY 2023: -17.4%FY 2024: -49.6%FY 2025: -89.8%
FY 2017 5y median -49.7% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income 12.0%
FY 2017: 0.0%FY 2018: -16.9%FY 2019: -223.2%FY 2020: -101.4%FY 2021: -14.5%FY 2022: 42.4%FY 2023: 33.4%FY 2024: -65.5%FY 2025: 12.0%
FY 2017 FY 2025
EPS (diluted) -28.2%
FY 2017: 0.0%FY 2018: -1.8%FY 2019: -232.8%FY 2020: -36.3%FY 2021: -15.2%FY 2022: 49.2%FY 2023: 45.5%FY 2024: -56.0%FY 2025: -28.2%
FY 2017 FY 2025
Free Cash Flow -29.9%
FY 2017: 0.0%FY 2018: -20.2%FY 2019: -179.9%FY 2020: -52.6%FY 2021: -24.1%FY 2022: 30.0%FY 2023: 58.2%FY 2024: -74.3%FY 2025: -29.9%
FY 2017 FY 2025

Financial Health

Current Ratio 0.5×
FY 2017: 4.3×FY 2018: 49.8×FY 2019: 11.9×FY 2020: 8.1×FY 2021: 7.9×FY 2022: 30.5×FY 2023: 8.1×FY 2024: 6.1×FY 2025: 0.5×
FY 2017 5y median 7.9× FY 2025
Quick Ratio 0.5×
FY 2017: 4.3×FY 2018: 49.8×FY 2019: 11.9×FY 2020: 8.1×FY 2021: 7.9×FY 2022: 30.5×FY 2023: 8.1×FY 2024: 6.1×FY 2025: 0.5×
FY 2017 5y median 7.9× FY 2025
Debt / Equity -0.5×
FY 2017: -0.4×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.2×FY 2024: 0.5×FY 2025: -0.5×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA -0.2×
FY 2017: 0.0×FY 2018: 2.1×FY 2019: 1.3×FY 2020: 0.8×FY 2021: 0.8×FY 2022: 0.9×FY 2023: 0.3×FY 2024: -0.2×FY 2025: -0.2×
FY 2017 5y median 0.3× FY 2025
Interest Coverage 0.0×
FY 2017: -6.3×FY 2018: -12.7×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -91.6×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31